Transcriptomics

Dataset Information

0

Therapeutic efficacy of INX-315, a selective CDK2 inhibitor, in solid tumors [HER2mouse resistant RNAseq]


ABSTRACT: We treated tumour-bearing MMTV-rtTA/tetO-HER2 female mice with 75 mg/kg Abemaciclib for ~4 weeks (or until point of resistance, where tumours have started to grow again). Mice were then divided into treatment groups, receiving vehicle (veh), INX-315 (INX), Abemaciclib (LY) or both INX-315 and Abema in combination (LY.INX). Resistant tumors were collected and RNA sequencing performed.

ORGANISM(S): Mus musculus

PROVIDER: GSE243148 | GEO | 2023/11/22

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2023-11-22 | GSE243149 | GEO
2023-11-22 | GSE243147 | GEO
2023-11-22 | GSE243152 | GEO
2023-11-22 | GSE243151 | GEO
2023-11-22 | GSE243153 | GEO
2023-11-22 | GSE243150 | GEO
| PRJNA1016438 | ENA
| PRJNA1016436 | ENA
| PRJNA1016443 | ENA
| PRJNA1016432 | ENA